Aetion Announces $36 Million in Series B Funding to Accelerate Its Platform for the Analysis of Real-World Evidence to Biopharma Companies and Health Care PayersCompany's technology helps those developing and purchasing medicines to uncover what works best - saving lives and money NEW YORK, April 11, 2018-- Aetion, the software platform company delivering the real-world analytics and evidence needed for biopharma and payers to engage in value-based care, announced it has raised $36.4 million in Series B funding.